Results 291 to 300 of about 114,451 (337)

Clinical Research Tool Demonstration (Demonstrator)

This deliverable will document how the clinical research tool in the PIBD cloud environment has aided the aims and objectives of the PIBD project.
openaire   +1 more source

Molecular characterisation of human penile carcinoma and generation of paired epithelial primary cell lines

Molecular Oncology, EarlyView.
Generation of two normal and tumour (cancerous) paired human cell lines using an established tissue culture technique and their characterisation is described. Cell lines were characterised at cellular, protein, chromosome and gene expression levels and for HPV status.
Simon Broad, Mahmood Hachim, Tom Bertin, Karolina Penderecka, Rifat Hamoudi, Saif Khan, Rui Henrique, Natalie Bergmoser, Manit Arya, Kalle Sipila, Matteo Vietri Rudan, Asif Muneer, Aamir Ahmed   +12 more
wiley   +1 more source

Racism in clinical nursing practice: a qualitative study. [PDF]

BMC Nurs
Crenshaw N, Lewis L, Foronda CL.
europepmc   +1 more source

Risk Management Method of Demonstrative Experiments for Mobile Robots in Outdoor Public Space:—Case Study Analysis of the "Real World Robot Challenge"—

, 2014
H. Igarashi, Tetsuya Kimura, Fumitoshi Matsuno   +2 more
openalex   +1 more source

Demonstratives of A-series in advertising copy -Focusing on the concept of deixis-

, 2020
YeongIm Doo
openalex   +1 more source

Cis‐regulatory and long noncoding RNA alterations in breast cancer – current insights, biomarker utility, and the critical need for functional validation

Molecular Oncology, EarlyView.
The noncoding region of the genome plays a key role in regulating gene expression, and mutations within these regions are capable of altering it. Researchers have identified multiple functional noncoding mutations associated with increased cancer risk in the genome of breast cancer patients.
Arnau Cuy Saqués, Aracele Martinez‐Mendez, John Crown, Alex Eustace   +3 more
wiley   +1 more source

Methylation biomarkers can distinguish pleural mesothelioma from healthy pleura and other pleural pathologies

Molecular Oncology, EarlyView.
We developed and validated a DNA methylation–based biomarker panel to distinguish pleural mesothelioma from other pleural conditions. Using the IMPRESS technology, we translated this panel into a clinically applicable assay. The resulting two classifier models demonstrated excellent performance, achieving high AUC values and strong diagnostic accuracy.
Janah Vandenhoeck, Nele De Meulenaere, Thomas Vanpoucke, Joe Ibrahim, Dieter Peeters, Suresh Krishan Yogeswaran, Wen Wen, Paul Van Schil, Jeroen M. H. Hendriks, Jo Raskin, Jan van Meerbeeck, Guy Van Camp, Ken Op de Beeck   +12 more
wiley   +1 more source

Developing a systems-focused tool for modeling lung cancer screening resource needs. [PDF]

Cost Eff Resour Alloc
Reddy A, Abe-Nornes F, Haskell A, Saito M, Schumacher M, Venkat A, Venkatasubramanian K, Woodhouse K, Zhang Y, Niktafar H, Leveque A, Kedroske B, Ramnath N, Cohn A.   +13 more
europepmc   +1 more source

Strength through diversity: how cancers thrive when clones cooperate

Molecular Oncology, EarlyView.
Intratumor heterogeneity can offer direct benefits to the tumor through cooperation between different clones. In this review, Kuiken et al. discuss existing evidence for clonal cooperativity to identify overarching principles, and highlight how novel technological developments could address remaining open questions.
Marije C. Kuiken, Maartje Witsen, Emile E. Voest, Krijn K. Dijkstra   +3 more
wiley   +1 more source

A multi-modal sensing system for human-robot interaction through tactile and proximity data. [PDF]

Front Robot AI
Laudante G, Mirto M, Pennacchio O, Pirozzi S.   +3 more
europepmc   +1 more source